RAD51D and breast carcinoma: Similarly, pathogenic variants of TP53, BRCA2, BRCA1, and RAD51D were significantly associated with early-onset breast cancer (Table 4), and pathogenic variants of TP53, BRCA2, BRCA1, and NBN were significantly associated with premenopausal breast cancer (Table 4).